American healthcare workers are making a significant move to Canada, driven by political instability in the U.S. and the allure of a progressive health system.
The Allurion Gastric Balloon System is now authorized by the US Food and Drug Administration for short-term weight loss in adults aged 22 to 65 years with obesity and a body mass index of 30 to 40 kg/m2.